Biotech

Health

FDA To Issue Guidelines For Using San Diego Device On Ebola Patients

City News Service

A San Diego medical group's blood purification device will be an available treatment for some qualified doctors to use.
Economy

Despite Rise Of ISIS, Isis Pharmaceuticals Will Keep Its Name

David Wagner

The rise of ISIS has triggered some rebranding efforts among organizations unlucky enough to share a name with the terrorist group. But one Carlsbad-based drug company is holding off on a name change.
Health

San Diego Biotech Lands Up To $42 Million For Ebola Drug Development

David Wagner

A U.S. health agency has awarded San Diego-based Mapp Biopharmaceutical new funding to speed up work on an experimental Ebola drug.
Health

San Diego Company Opens Up About Experimental Ebola Drug

David Wagner

After weeks of shying away from the news media, the head of a small San Diego drug company finally talked publicly about his company's experimental Ebola treatment ZMapp.
Health

African Doctor Treated With San Diego Company's Ebola Drug Dies

David Wagner

A Liberian doctor's death is the second among the six people treated with ZMapp, an experimental drug to treat Ebola made by a San Diego-based biotech.
KPBS Evening Edition

Judging An Ebola Drug In The Middle Of A Crisis

David Wagner

In most cases, Ebola is a death sentence. But most of the infected patients who've taken a San Diego company's experimental drug have lived. Does that mean it works?
Health

San Diego Company Exhausts Supply Of Ebola Drug

David Wagner

The San Diego company behind an experimental Ebola treatment given to two American health workers last week is now out of the drug. The last available samples have been donated to West Africa.
Science & Technology

2 Aid Workers Receive Experimental Ebola Serum From San Diego Biotech

City News Service

KPBS Staff

Associated Press

Dr. Kent Brantly and Nancy Writebol, infected with Ebola while working in West Africa, were given ZMapp, a drug created by Mapp Biopharmaceutical in San Diego.
Science & Technology

Scripps Research Institute President Stepping Down

KPBS Staff

Less than two weeks after ending talks aimed at merging with a major university in Southern California, the Scripps Research Institute has announced the resignation of its president, Mike Marletta.
Science & Technology

Scripps Research Institute Ends Merger Talks With USC

City News Service

The merger would have allowed the Scripps Research Institute to receive less of its $310 million annual operating budget from the National Institutes of Health, and would have added to USC's prestigious life-science institutes.